SNGX
Soligenix Inc.
NASDAQ: SNGX · HEALTHCARE · BIOTECHNOLOGY
$0.35
+2.07% today
Updated 2026-04-30
Market cap
$4.34M
P/E ratio
—
P/S ratio
9.78x
EPS (TTM)
$-2.14
Dividend yield
—
52W range
$0 – $6
Volume
0.6M
Soligenix Inc. (SNGX) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-235.50%
ROA
-81.40%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2006 | $2.31M | $-8.16M | 15.04% | -354.52% | -352.92% |
| 2007 | $1.26M | $-6.17M | 25.01% | -502.94% | -490.06% |
| 2008 | $2.31M | $-3.42M | 18.35% | -149.61% | -148.14% |
| 2009 | $2.82M | $-6.03M | 47.30% | -214.88% | -214.28% |
| 2010 | $1.95M | $-7.39M | 15.87% | -404.41% | -379.21% |
| 2011 | $7.66M | $-2.38M | 72.49% | -38.63% | -31.05% |
| 2012 | $3.15M | $-4.16M | 17.54% | -149.16% | -132.37% |
| 2013 | $3.22M | $-10.06M | 21.09% | -221.99% | -312.00% |
| 2014 | $7.04M | $-6.71M | 24.55% | -152.79% | -95.23% |
| 2015 | $8.77M | $-7.83M | 21.51% | -81.09% | -89.31% |
| 2016 | $10.45M | $-3.25M | 19.28% | -54.65% | -31.06% |
| 2017 | $5.43M | $-7.15M | 20.66% | -139.80% | -131.57% |
| 2018 | $5.24M | $-8.90M | 12.28% | -172.85% | -169.81% |
| 2019 | $3.22M | $-9.36M | -10.94% | -327.80% | -290.94% |
| 2020 | $1.93M | $-17.69M | 5.68% | -962.77% | -916.25% |
| 2021 | $33351.00 | $-12.55M | -2,084.76% | -39,276.06% | -37,632.97% |
| 2022 | $250000.00 | $-13.80M | -120.33% | -5,695.56% | -5,519.34% |
| 2023 | $839359.00 | $-6.14M | -88.41% | -917.12% | -731.60% |
| 2024 | $119371.00 | $-8.27M | -100.00% | -7,907.70% | -6,925.11% |
| 2025 | $0.00 | $-11.08M | — | — | — |